Skip to main content
Lasa Supergenerics Limited logo

Lasa Supergenerics Limited — Investor Relations & Filings

Ticker · LASA ISIN · INE670X01014 LEI · 984500B9EA5EC3R2F726 BSE.NS Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2024-06-29 Regulatory Filings
Country IN India
Listing BSE.NS LASA

About Lasa Supergenerics Limited

https://lasalabs.com/

Lasa Supergenerics Limited is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs) for both veterinary and human health applications. The company focuses on the research, development, and production of high-quality chemical intermediates and APIs. Its core product portfolio includes a significant range of anthelmintics, such as Albendazole, Fenbendazole, and Ricobendazole, alongside other specialized therapeutic categories. Utilizing advanced manufacturing facilities and a dedicated research and development wing, the organization emphasizes cost-effective production processes and stringent quality control standards. Lasa Supergenerics Limited serves a global clientele, providing essential components for pharmaceutical formulations and animal health products through its expertise in complex chemical synthesis and large-scale manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window for insiders ahead of the unaudited financial results for the quarter ended June 30, 2024. It references the upcoming financial results but does not contain any financial data or the results themselves. The document is a regulatory announcement related to insider trading compliance and trading restrictions, not a financial report or earnings release. Given its short length (1640 characters) and nature as an announcement, it fits best under Regulatory Filings (RNS).
2024-06-29 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the outcome of a postal ballot conducted by LASA Supergenerics Limited. It includes voting results, resolution details, and a scrutinizer's report confirming the approval of the appointment of an executive director. The document references compliance with SEBI Listing Regulations and Companies Act, 2013, and provides detailed voting statistics and procedural information. It does not contain financial statements or management discussion of financial results, nor is it a transcript or presentation. It is not a report publication announcement since it contains substantive voting results and scrutinizer's report. The content fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the results of shareholder voting conducted via postal ballot.
2024-06-26 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions for the year ended March 31, 2024, and also includes related party transactions for the half year ended September 30, 2023. It is addressed to stock exchanges and references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, specifically Regulation 23(9). The content focuses on related party transactions, including remuneration and sitting fees for directors and key management personnel. It does not contain full financial statements or comprehensive financial analysis, nor is it an announcement of a report publication. The document is a regulatory disclosure related to related party transactions, which typically falls under Regulatory Filings (RNS) as it does not fit the definitions of other specific report types such as Annual Report, Interim Report, or Remuneration Information (DEF 14A) which usually are more detailed and formal reports. Therefore, the best classification is Regulatory Filings (RNS).
2024-05-30 English
Financial Result Updates
Regulatory Filings
2024-05-30 English
Outcome of Board Meeting
Regulatory Filings
2024-05-30 English
Board Meeting — LASA SUPERGENERICS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for…
Regulatory Filings
2024-05-24 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.